NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

US-Iran Talks: Progress Made Towards Ending War, Final Agreement in Sight

President Donald Trump announced on Saturday that negotiations between the United States and Iran were nearing a final agreement to bring an end to the ongoing conflict. According to an interview with CBS News, Trump stated that a final agreement would prevent Iran from obtaining a nuclear weapon and ensure that the country's enriched uranium would be "satisfactorily handled."

The latest developments come as the United States, Iran, and mediator Pakistan reported progress in talks aimed at ending almost three months of war. Trump indicated that he would discuss the latest draft agreement with his advisers on Saturday and may make a decision on whether to resume the war by Sunday.

The talks have been ongoing since a ceasefire was declared six weeks ago to allow the sides to come to agreement on Iran's nuclear program and the reopening of the Strait of Hormuz, a critical oil and gas supply route controlled by Tehran. Trump has consistently maintained a hardline stance, stating that he would only sign a deal where the US "gets everything we want."

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

EntityStance on Iran's Nuclear Program
United StatesPrevent Iran from obtaining a nuclear weapon
IranNo clear stance mentioned
PakistanMediator, progress reported in talks
IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.